Controversial critic of COVID-19 lockdowns confirmed as new NIH director, vowing to foster scientific dissent.
McCormick's Q1 earnings miss amid tariff pressures, but the company maintains its full-year outlook and emphasizes cost savings and strategic price adjustments.
Waltz's NSA role in jeopardy after Yemen leak as administration faces scrutiny and calls for resignations
Controversial critic of COVID-19 lockdowns confirmed as new NIH director, vowing to foster scientific dissent.
McCormick's Q1 earnings miss amid tariff pressures, but the company maintains its full-year outlook and emphasizes cost savings and strategic price adjustments.
Waltz's NSA role in jeopardy after Yemen leak as administration faces scrutiny and calls for resignations